Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry
暂无分享，去创建一个
C. Enzinger | F. Leutmezer | T. Berger | E. Kvas | J. Kraus | On behalf of the OCEAN-TAVI Registry | M. Guger | S. Kalcher | Guger Michael | Enzinger Christian | Leutmezer Fritz | K. Jörg | Kalcher Stefan | K. Erich | B. Thomas